Artelo Biosciences, Inc. (ARTL): EPS (Diluted)
-$12.52
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$12.52 | n/m | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | -$18.30 | n/c | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | -$3.14 | n/a | 2025-03-03, From 2023-01-01 |
| No annual figure between 2019-08-31 and 2023-12-31. | |||
| 2019-08-31 | -$1.46 | n/m | 2019-12-18, From 2018-09-01 |
| 2018-08-31 | -$1.84 | n/a | 2019-12-18, From 2017-09-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$12.52 | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$0.63 | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$3.20 | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$4.79 | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$2.20 | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$8.88 | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | -$3.12 | n/m |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | -$0.88 | n/m |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | -$0.02 | n/m |
Compare ARTL, BFRG, NTHI, LIPO side by side · Screen every company in Pharmaceutical Preparations ↗